Literature DB >> 24264465

Breast cancer patients with metastatic spinal cord compression. Number of extraspinal organs involved by metastases influences survival.

A Weber1, T Bartscht, J H Karstens, S E Schild, D Rades.   

Abstract

BACKGROUND AND
PURPOSE: The goal of the present work was to investigate the predictive value of the number of extraspinal organs involved by metastases for the survival of patients with metastatic spinal cord compression (MSCC) from breast cancer. PATIENTS AND METHODS: Data of 145 breast cancer patients who received 10 fractions of 3 Gy of radiotherapy (RT) alone for MSCC were retrospectively analyzed. Seven potential prognostic factors were investigated including age, Eastern Cooperative Oncology Group (ECOG) performance score, number of involved vertebrae, interval from breast cancer diagnosis to RT of MSCC, ambulatory status prior to RT, time to developing motor deficits, and the number of involved extraspinal organs.
RESULTS: The 1-year survival rates for involvement of 0, 1, 2, and ≥ 3 extraspinal organs were 86, 73, 36, and 16 % (p < 0.001). In the multivariate analysis, the number of involved extraspinal organs remained significant (risk ratio 2.19; 95 % confidence interval 1.61-3.00; p < 0.001). ECOG performance score (p < 0.001), ambulatory status prior to RT (p = 0.003), and the time to developing motor deficits (p < 0.001) were also significantly associated with survival in the multivariate analysis.
CONCLUSION: The number of extraspinal organs involved by metastases is an independent prognostic factor of survival in patients with MSCC from breast cancer.

Entities:  

Mesh:

Year:  2013        PMID: 24264465     DOI: 10.1007/s00066-013-0473-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

1.  Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.

Authors:  Dirk Rades; Marisa Lange; Theo Veninga; Lukas J A Stalpers; Amira Bajrovic; Irenaeus A Adamietz; Volker Rudat; Steven E Schild
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-06       Impact factor: 7.038

2.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.

Authors:  Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

Review 3.  Malignant spinal-cord compression.

Authors:  Dheerendra Prasad; David Schiff
Journal:  Lancet Oncol       Date:  2005-01       Impact factor: 41.316

4.  Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?

Authors:  D Rades; S Huttenlocher; J N Evers; A Bajrovic; J H Karstens; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

5.  Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Authors:  Dirk Rades; Lukas J A Stalpers; Theo Veninga; Rainer Schulte; Peter J Hoskin; Nermina Obralic; Amira Bajrovic; Volker Rudat; Rudolf Schwarz; Maarten C Hulshof; Philip Poortmans; Steven E Schild
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

6.  Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial.

Authors:  Ernesto Maranzano; Rita Bellavita; Romina Rossi; Verena De Angelis; Alessandro Frattegiani; Rita Bagnoli; Marcello Mignogna; Sara Beneventi; Marco Lupattelli; Pietro Ponticelli; Gian Paolo Biti; Paolo Latini
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

7.  Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.

Authors:  D Rades; S Douglas; T Veninga; L J A Stalpers; A Bajrovic; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-23       Impact factor: 3.621

Review 8.  Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials.

Authors:  Kristopher Dennis; Leila Makhani; Liang Zeng; Henry Lam; Edward Chow
Journal:  Radiother Oncol       Date:  2013-01-13       Impact factor: 6.280

Review 9.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  A validated survival score for breast cancer patients with metastatic spinal cord compression.

Authors:  D Rades; S Douglas; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-11-10       Impact factor: 3.621

View more
  3 in total

Review 1.  A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).

Authors:  A González; A Lluch; E Aba; J Albanell; A Antón; I Álvarez; F Ayala; A Barnadas; L Calvo; E Ciruelos; J Cortés; J de la Haba; J M López-Vega; E Martínez; M Muñoz; I Peláez; A Redondo; Á Rodríguez; C A Rodríguez; A Ruíz; A Llombart
Journal:  Clin Transl Oncol       Date:  2016-11-16       Impact factor: 3.405

2.  Patient-reported symptoms before palliative radiotherapy predict survival differences.

Authors:  Carsten Nieder; Thomas A Kämpe; Adam Pawinski; Astrid Dalhaug
Journal:  Strahlenther Onkol       Date:  2018-01-17       Impact factor: 3.621

Review 3.  Prognostic Factors for Bone Survival and Functional Outcomes in Patients With Breast Cancer Spine Metastases.

Authors:  Rui-Qi Qiao; Hao-Ran Zhang; Rong-Xing Ma; Rui-Feng Li; Yong-Cheng Hu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.